ImmuPharma’s chairman, Tim McCarthy, talks on widening of portfolio and focus on partnering opportunities – 13 April 2020

14th April 2020 - 11:00 am

ImmuPharma PLC’s (LON:IMM) Tim McCarthy caught up with Proactive London’s Andrew Scott soon after the firm announced it had raised £1.5mln from a share subscription to fund an expansion of its research & development programmes.

Share this article